| ABCG2: a perspective RW Robey, KKK To, O Polgar, M Dohse, P Fetsch, M Dean, SE Bates Advanced drug delivery reviews 61 (1), 3-13, 2009 | 539 | 2009 |
| Platinum‐based anticancer agents: Innovative design strategies and biological perspectives YP Ho, SCF Au‐Yeung, KKW To Medicinal research reviews 23 (5), 633-655, 2003 | 440 | 2003 |
| HIF-1α induces genetic instability by transcriptionally downregulating MutSα expression M Koshiji, KKW To, S Hammer, K Kumamoto, AL Harris, P Modrich, ... Molecular cell 17 (6), 793-803, 2005 | 426 | 2005 |
| Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters Y Mi, Y Liang, H Huang, H Zhao, CP Wu, F Wang, L Tao, C Zhang, CL Dai, ... Cancer research 70 (20), 7981-7991, 2010 | 379 | 2010 |
| Recent advances in the treatment of breast cancer CWS Tong, M Wu, WCS Cho, KKW To Frontiers in oncology 8, 227, 2018 | 285 | 2018 |
| A gold@ polydopamine core–shell nanoprobe for long-term intracellular detection of microRNAs in differentiating stem cells CKK Choi, J Li, K Wei, YJ Xu, LWC Ho, M Zhu, KKW To, CHJ Choi, L Bian Journal of the American Chemical Society 137 (23), 7337-7346, 2015 | 218 | 2015 |
| Regulation of ABCG2 expression at the 3′ untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 … KKW To, Z Zhan, T Litman, SE Bates Molecular and cellular biology 28 (17), 5147-5161, 2008 | 195 | 2008 |
| MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside KKW To, CWS Tong, M Wu, WCS Cho World journal of gastroenterology 24 (27), 2949, 2018 | 193 | 2018 |
| Aberrant Promoter Methylation of the ABCG2 Gene in Renal Carcinoma KKW To, Z Zhan, SE Bates Molecular and cellular biology 26 (22), 8572-8585, 2006 | 163 | 2006 |
| Histone Modifications at the ABCG2 Promoter following Treatment with Histone Deacetylase Inhibitor Mirror Those in Multidrug-Resistant Cells KKW To, O Polgar, LM Huff, K Morisaki, SE Bates Molecular cancer research 6 (1), 151-164, 2008 | 154 | 2008 |
| Apatinib (YN968D1) enhances the efficacy of conventional chemotherapeutical drugs in side population cells and ABCB1-overexpressing leukemia cells X Tong, F Wang, S Liang, X Zhang, J He, XG Chen, Y Liang, Y Mi, ... Biochemical pharmacology 83 (5), 586-597, 2012 | 150 | 2012 |
| Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes AM Calcagno, JM Fostel, KKW To, CD Salcido, SE Martin, KJ Chewning, ... British journal of cancer 98 (9), 1515-1524, 2008 | 147 | 2008 |
| The phosphorylation status of PAS‐B distinguishes HIF‐1α from HIF‐2α in NBS1 repression KKW To, OA Sedelnikova, M Samons, WM Bonner, LE Huang The EMBO journal 25 (20), 4784-4794, 2006 | 147 | 2006 |
| Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2 KKW To, RW Robey, T Knutsen, Z Zhan, T Ried, SE Bates Molecular cancer therapeutics 8 (10), 2959-2968, 2009 | 142 | 2009 |
| Suppression of hypoxia-inducible factor 1α (HIF-1α) transcriptional activity by the HIF prolyl hydroxylase EGLN1 KKW To, LE Huang Journal of Biological Chemistry 280 (45), 38102-38107, 2005 | 131 | 2005 |
| Anthracenedione derivatives as anticancer agents isolated from secondary metabolites of the mangrove endophytic fungi J Zhang, L Tao, Y Liang, L Chen, Y Mi, L Zheng, F Wang, Z She, Y Lin, ... Marine drugs 8 (4), 1469-1481, 2010 | 119 | 2010 |
| Potential new antitumor agents from an innovative combination of demethylcantharidin, a modified traditional Chinese medicine, with a platinum moiety YP Ho, KKW To, SCF Au-Yeung, X Wang, G Lin, X Han Journal of medicinal chemistry 44 (13), 2065-2068, 2001 | 114 | 2001 |
| Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines S Chai, KKW To, G Lin Chinese medicine 5, 1-9, 2010 | 113 | 2010 |
| Updates on the use of liposomes for active tumor targeting in cancer therapy W Yan, SSY Leung, KKW To Nanomedicine 15 (3), 303-318, 2020 | 108 | 2020 |
| Crizotinib (PF‐02341066) reverses multidrug resistance in cancer cells by inhibiting the function of P‐glycoprotein W Zhou, X Zhang, C Cheng, F Wang, X Wang, Y Liang, KKW To, W Zhou, ... British journal of pharmacology 166 (5), 1669-1683, 2012 | 104 | 2012 |
